Reviewed by Dr. C.H. Weaver M.D. Medical editor 3/2021
Cancer patients undergo many different types of tests in order to accurately diagnose their disease, determine their prognosis, and monitor their cancer for progression or recurrence.The term “diagnostic test” can be misleading, as these tests are not used only for diagnosing cancer, but also for monitoring cancer progression. There are many reasons for employing diagnostic tests depending on whether the disease is active or progressing, being treated, or in remission. Diagnostic tests may be used to:
- Diagnose primary disease—identify the disease the first time it occurs
- Identify cancer subtype—some cancers are divided into subtypes that are more or less aggressive; identification of a more aggressive subtype may influence the type of treatment proposed
- Predict prognosis—test results may indicate chance of cure, based on outcomes of other patients with similar results
- Direct treatment—cancer is many different diseases, all of which respond differently to various treatments. A diagnosis that accurately identifies the type of cancer and predicts prognosis will also help to identify the type of treatment that maximizes chance of cure.
- Evaluate response to treatment—some tests show whether the cancer is responding to treatment
- Detect minimal residual disease—cancer cells that remain after treatment is completed are called (MRD). Detection of MRD may indicate a higher likelihood of recurrence.
- Monitor remission or progression—if a cancer is in remission, frequent tests may help detect the cancer if it returns and/or determine whether it is progressing
- Screen at-risk individuals—identifying abnormalities in cells or the DNA of cells of asymptomatic (healthy) individuals may indicate an increased risk (although not a certainty) of developing disease
The testing center provides an overview and explanation of all the tests used by doctors that are related to predicting, detecting, diagnosing, and monitoring cancer. Broadly, these tests fall into broad categories that includes Genetic Tests, and Diagnostic and Surveillance tests which are described below.
Genomics generally refers to the study of the study of the entire genome (all of the DNA in an organism). Genomics can consider multiple genes and how they interact with each other and the environment to affect health. Genomic testing is routinely performed on cancer cells to determine whether precision cancer medicines can be used to target specific cancer growth driving mutations. Research in genomics is expanding at a rapid rate and will have a profound effect on many aspects of disease prevention, diagnosis, and treatment. Diseases such as cancer are remarkably complex; genomics provides researchers and physicians with tools to explore and address these complexities.
Genetic Tests are used to determine if an individual has an inherited genetic mutation that substantially increases the risk of certain types of cancer. For example, women with a BRCA1 or BRCA2 gene mutation have a high risk of developing breast or ovarian cancer. Women who learn that they carry one of these mutations can take steps to reduce their risk of developing cancer or to detect it at the earliest stage possible. Specific genetic tests are increasingly being defined for a growing number of cancers; To learn more about genetic testing, visit Genetic Tests.
Nubeqa Delays Prostate Cancer Progression in Resistant Prostate Cancer
Nubeqa delays cancer progression and prolongs survival for men with a rising PSA but no evidence of metastases.
Diagnostic Testing & Evaluation
Diagnostic Tests are used to accurately diagnose cancer and other diseases, determine prognosis, and monitor cancer recurrence and the safety of treatment. Diagnostic tests are used to diagnose primary disease, identify cancer subtype, predict prognosis, direct treatment, evaluate response to treatment, detect minimal residual disease, and monitor remission or progression. There are a number of diagnostic tests that fall into the following categories:
Pathology Tests: Pathology tests involve microscopic evaluation of abnormal cells.
Diagnostic Imaging: Diagnostic imaging involves visualization of abnormal masses using high-tech machines that create images. Examples of diagnostic imaging include x-rays, computed tomography (CT) scans, positron emission tomography (PET) scans, magnetic resonance imaging (MRI), and combined PET/CT scans.
Blood Tests:Blood tests measure substances in the blood that may indicate how advanced the cancer is or other problems related to the cancer.
Tumor Markers: Tumor marker tests detect substances in blood, urine, or other tissues that occur in higher than normal levels with certain cancers.
Genomic Tests: Special laboratory evaluation of DNA involves the identification of the genetic make-up-the DNA-of the abnormal cells.